GlassScriptPhysician profile
Crystal N Gonzalez
NPI 1326297144
$7,652.05
in general payments reported to CMS, 2019-2025
14 companies · $19.64 in 2025
The $19.64 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,235 · 2020: $2,522 · 2021: $1,401 · 2022: $293 · 2023: $181 · 2025: $19.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $6,008.97 | 2019-2022 | |
| Organogenesis INC. | $344.39 | 2019-2022 | |
| Smith+Nephew, INC. | $319.70 | 2019-2023 | Collagenase Santyl, Regranex, Versajet |
| Wright Medical Technology, INC. | $291.52 | 2019-2020 | |
| Depuy Synthes Sales INC. | $175.81 | 2019-2023 | Hammerlock, Na, Lcp |
| Stryker Corporation | $171.68 | 2020-2023 | Sonicpin |
| Acell, INC. | $121.49 | 2019 | |
| Medartis INC. | $64.93 | 2019 | |
| Bioventus LLC | $43.19 | 2019 | |
| Integra Lifesciences Corporation | $34.77 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $26.39 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Eclipse Technology Solutions INC. | $19.64 | 2025 | |
| Abbvie INC. | $15.63 | 2023 | |
| Kci USA, INC. | $13.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.